Luye Pharma Hong Kong Limited - Net Worth and Insider Trading

Luye Pharma Hong Kong Limited Net Worth

The estimated net worth of Luye Pharma Hong Kong Limited is at least $3.3 Billion dollars as of 2024-06-22. Luye Pharma Hong Kong Limited is the of Shandong Boan Biotechnology Co Ltd and owns about 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) stock worth over $3.3 Billion. Details can be seen in Luye Pharma Hong Kong Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Luye Pharma Hong Kong Limited has not made any transactions after 2024-04-12 and currently still holds the listed stock(s).

Transaction Summary of Luye Pharma Hong Kong Limited

To

Luye Pharma Hong Kong Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luye Pharma Hong Kong Limited owns 1 companies in total, including Shandong Boan Biotechnology Co Ltd (HKSE:06955) .

Click here to see the complete history of Luye Pharma Hong Kong Limited’s form 4 insider trades.

Insider Ownership Summary of Luye Pharma Hong Kong Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:06955 Shandong Boan Biotechnology Co Ltd 2024-04-12

Luye Pharma Hong Kong Limited Latest Holdings Summary

Luye Pharma Hong Kong Limited currently owns a total of 1 stock. Luye Pharma Hong Kong Limited owns 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) as of April 12, 2024, with a value of $3.3 Billion.

Latest Holdings of Luye Pharma Hong Kong Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06955 Shandong Boan Biotechnology Co Ltd 2024-04-12 360,596,456 9.19 3,313,881,431

Holding Weightings of Luye Pharma Hong Kong Limited


Luye Pharma Hong Kong Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Luye Pharma Hong Kong Limited has made a total of 4 transactions in Shandong Boan Biotechnology Co Ltd (HKSE:06955) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shandong Boan Biotechnology Co Ltd is the sale of 0 shares on April 12, 2024, which brought Luye Pharma Hong Kong Limited around $0.

Insider Trading History of Luye Pharma Hong Kong Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luye Pharma Hong Kong Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Luye Pharma Hong Kong Limited Ownership Network

Ownership Network List of Luye Pharma Hong Kong Limited

No Data

Ownership Network Relation of Luye Pharma Hong Kong Limited

Insider Network Chart

Luye Pharma Hong Kong Limited Owned Company Details

What does Shandong Boan Biotechnology Co Ltd do?

Who are the key executives at Shandong Boan Biotechnology Co Ltd?

Luye Pharma Hong Kong Limited is the of Shandong Boan Biotechnology Co Ltd. Other key executives at Shandong Boan Biotechnology Co Ltd include AsiaPharm Investments Ltd. , Ginkgo (PTC) Limited , and Liu Dianbo .

Shandong Boan Biotechnology Co Ltd (HKSE:06955) Insider Trades Summary

Over the past 18 months, Luye Pharma Hong Kong Limited made 4 insider transaction in Shandong Boan Biotechnology Co Ltd (HKSE:06955) with a net sale of 0. Other recent insider transactions involving Shandong Boan Biotechnology Co Ltd (HKSE:06955) include a net sale of 0 shares made by Luye Pharma Group Ltd. , a net sale of 0 shares made by LuYe Pharmaceutical International Co., Ltd. , and a net sale of 0 shares made by Nelumbo Investments Limited .

In summary, during the past 3 months, insiders sold 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shandong Boan Biotechnology Co Ltd (HKSE:06955)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shandong Boan Biotechnology Co Ltd Insider Transactions

No Available Data

Luye Pharma Hong Kong Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Luye Pharma Hong Kong Limited. Currently GuruFocus does not have mailing address information for Luye Pharma Hong Kong Limited.

Discussions on Luye Pharma Hong Kong Limited

No discussions yet.